| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | TSP_1 | 7.18e-04 | 63 | 52 | 3 | PF00090 | |
| Domain | EGF-like_CS | 7.80e-04 | 261 | 52 | 5 | IPR013032 | |
| Domain | TSP1 | 7.87e-04 | 65 | 52 | 3 | SM00209 | |
| Domain | TSP1_rpt | 7.87e-04 | 65 | 52 | 3 | IPR000884 | |
| Domain | TSP1 | 7.87e-04 | 65 | 52 | 3 | PS50092 | |
| Domain | EGF_2 | 8.35e-04 | 265 | 52 | 5 | PS01186 | |
| Domain | EGF_CA | 1.77e-03 | 86 | 52 | 3 | PF07645 | |
| Domain | TSPN | 1.85e-03 | 23 | 52 | 2 | SM00210 | |
| Domain | FHA | 2.74e-03 | 28 | 52 | 2 | SM00240 | |
| Domain | VWC | 2.74e-03 | 28 | 52 | 2 | PF00093 | |
| Domain | FHA_DOMAIN | 3.36e-03 | 31 | 52 | 2 | PS50006 | |
| Domain | FHA | 3.36e-03 | 31 | 52 | 2 | PF00498 | |
| Domain | EGF_3 | 4.12e-03 | 235 | 52 | 4 | PS50026 | |
| Domain | EGF | 4.12e-03 | 235 | 52 | 4 | SM00181 | |
| Domain | FHA_dom | 4.51e-03 | 36 | 52 | 2 | IPR000253 | |
| Domain | VWFC_1 | 4.51e-03 | 36 | 52 | 2 | PS01208 | |
| Domain | - | 4.51e-03 | 36 | 52 | 2 | 2.60.200.20 | |
| Domain | EGF_CA | 4.76e-03 | 122 | 52 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.98e-03 | 124 | 52 | 3 | IPR001881 | |
| Domain | VWC | 5.01e-03 | 38 | 52 | 2 | SM00214 | |
| Domain | VWFC_2 | 5.01e-03 | 38 | 52 | 2 | PS50184 | |
| Domain | EGF-like_dom | 5.06e-03 | 249 | 52 | 4 | IPR000742 | |
| Domain | EGF_1 | 5.50e-03 | 255 | 52 | 4 | PS00022 | |
| Domain | VWF_dom | 6.10e-03 | 42 | 52 | 2 | IPR001007 | |
| Domain | FERM_M | 7.28e-03 | 46 | 52 | 2 | PF00373 | |
| Domain | CUB | 8.22e-03 | 49 | 52 | 2 | PF00431 | |
| Domain | - | 8.22e-03 | 49 | 52 | 2 | 1.20.80.10 | |
| Domain | FERM_central | 8.22e-03 | 49 | 52 | 2 | IPR019748 | |
| Domain | FERM_domain | 8.22e-03 | 49 | 52 | 2 | IPR000299 | |
| Domain | FERM_1 | 8.55e-03 | 50 | 52 | 2 | PS00660 | |
| Domain | FERM_2 | 8.55e-03 | 50 | 52 | 2 | PS00661 | |
| Domain | FERM_3 | 8.55e-03 | 50 | 52 | 2 | PS50057 | |
| Domain | Band_41_domain | 8.55e-03 | 50 | 52 | 2 | IPR019749 | |
| Domain | CUB | 8.55e-03 | 50 | 52 | 2 | SM00042 | |
| Pubmed | Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration. | 2.73e-06 | 2 | 58 | 2 | 33990369 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21949402 | ||
| Pubmed | 7.75e-06 | 75 | 58 | 4 | 20637190 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16487505 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 28520920 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16263504 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15213514 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 14527840 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 35585091 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 30210296 | ||
| Pubmed | TMEM216 promotes primary ciliogenesis and Hedgehog signaling through the SUFU-GLI2/GLI3 axis. | 5.71e-05 | 7 | 58 | 2 | 38261656 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 7.60e-05 | 8 | 58 | 2 | 33875569 | |
| Pubmed | 9.01e-05 | 140 | 58 | 4 | 26930384 | ||
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 38848388 | ||
| Pubmed | Exocrine glands and the Chievitz organ of some mouse mutants. | 9.77e-05 | 9 | 58 | 2 | 5088022 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 28781964 | ||
| Pubmed | Follistatin interacts with Noggin in the development of the axial skeleton. | 1.22e-04 | 10 | 58 | 2 | 24514266 | |
| Pubmed | Sonic hedgehog is not a limb morphogen but acts as a trigger to specify all digits in mice. | 1.22e-04 | 10 | 58 | 2 | 35977544 | |
| Pubmed | FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. | 1.22e-04 | 10 | 58 | 2 | 25402856 | |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.22e-04 | 10 | 58 | 2 | 15345741 | |
| Pubmed | 1.46e-04 | 300 | 58 | 5 | 28561026 | ||
| Pubmed | Gli3 is required for maintenance and fate specification of cortical progenitors. | 1.49e-04 | 11 | 58 | 2 | 21525285 | |
| Pubmed | 1.78e-04 | 167 | 58 | 4 | 22159717 | ||
| Pubmed | A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. | 1.78e-04 | 12 | 58 | 2 | 20508144 | |
| Pubmed | Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. | 1.78e-04 | 12 | 58 | 2 | 10981962 | |
| Pubmed | Vsx2/Chx10 ensures the correct timing and magnitude of Hedgehog signaling in the mouse retina. | 1.78e-04 | 12 | 58 | 2 | 18417110 | |
| Pubmed | SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | 1.78e-04 | 12 | 58 | 2 | 31911863 | |
| Pubmed | 1.78e-04 | 12 | 58 | 2 | 30093555 | ||
| Pubmed | 1.90e-04 | 503 | 58 | 6 | 16964243 | ||
| Pubmed | Expression patterns of Hedgehog signalling pathway members during mouse palate development. | 2.11e-04 | 13 | 58 | 2 | 16168717 | |
| Pubmed | Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development. | 2.11e-04 | 13 | 58 | 2 | 25448692 | |
| Pubmed | Analysis of transcription factors expressed at the anterior mouse limb bud. | 2.11e-04 | 13 | 58 | 2 | 28467430 | |
| Pubmed | Gli2 influences proliferation in the developing lung through regulation of cyclin expression. | 2.11e-04 | 13 | 58 | 2 | 19574535 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 2.11e-04 | 13 | 58 | 2 | 36335435 | |
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 34679163 | ||
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 37300483 | ||
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 26728556 | ||
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 23313125 | ||
| Pubmed | Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. | 2.46e-04 | 14 | 58 | 2 | 24076664 | |
| Pubmed | 3.23e-04 | 16 | 58 | 2 | 24633704 | ||
| Pubmed | A conserved molecular logic for neurogenesis to gliogenesis switch in the cerebral cortex. | 3.23e-04 | 16 | 58 | 2 | 38713624 | |
| Pubmed | 3.23e-04 | 16 | 58 | 2 | 24726283 | ||
| Pubmed | Overactivation of hedgehog signaling alters development of the ovarian vasculature in mice. | 3.66e-04 | 17 | 58 | 2 | 22402963 | |
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 16957084 | ||
| Pubmed | Spatiotemporal regulation of GLI target genes in the mammalian limb bud. | 4.02e-04 | 207 | 58 | 4 | 26238476 | |
| Pubmed | 4.11e-04 | 18 | 58 | 2 | 26509897 | ||
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 4.59e-04 | 19 | 58 | 2 | 17664336 | |
| Pubmed | 4.59e-04 | 19 | 58 | 2 | 32234482 | ||
| Pubmed | Cooperative activity of noggin and gremlin 1 in axial skeleton development. | 4.59e-04 | 19 | 58 | 2 | 21303853 | |
| Pubmed | Specific requirement of Gli transcription factors in Hedgehog-mediated intestinal development. | 4.59e-04 | 19 | 58 | 2 | 23645682 | |
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 4.59e-04 | 19 | 58 | 2 | 28916710 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 4.74e-04 | 1105 | 58 | 8 | 35748872 | |
| Pubmed | The epigenetic state of EED-Gli3-Gli1 regulatory axis controls embryonic cortical neurogenesis. | 5.09e-04 | 20 | 58 | 2 | 35931079 | |
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 30843579 | ||
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 20081193 | ||
| Pubmed | Differential requirement of SUFU in tissue development discovered in a hypomorphic mouse model. | 5.62e-04 | 21 | 58 | 2 | 28688895 | |
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 14745966 | ||
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 28794157 | ||
| Pubmed | Identification of the Mitochondrial Heme Metabolism Complex. | 5.62e-04 | 21 | 58 | 2 | 26287972 | |
| Pubmed | 5.90e-04 | 407 | 58 | 5 | 12693553 | ||
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 35245678 | ||
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 28432216 | ||
| Pubmed | Primary cilia regulate hippocampal neurogenesis by mediating sonic hedgehog signaling. | 6.76e-04 | 23 | 58 | 2 | 18728187 | |
| Pubmed | 7.37e-04 | 24 | 58 | 2 | 18171685 | ||
| Pubmed | 7.37e-04 | 24 | 58 | 2 | 23552073 | ||
| Pubmed | 7.37e-04 | 24 | 58 | 2 | 12403705 | ||
| Pubmed | Dual mechanism underlying failure of neural tube closure in the Zic2 mutant mouse. | 7.37e-04 | 24 | 58 | 2 | 36916392 | |
| Pubmed | Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo. | 7.37e-04 | 24 | 58 | 2 | 20573697 | |
| Pubmed | 8.00e-04 | 25 | 58 | 2 | 26143639 | ||
| Pubmed | 8.00e-04 | 25 | 58 | 2 | 29587143 | ||
| Pubmed | 8.00e-04 | 25 | 58 | 2 | 32840212 | ||
| Pubmed | Ofd1 controls dorso-ventral patterning and axoneme elongation during embryonic brain development. | 8.66e-04 | 26 | 58 | 2 | 23300826 | |
| Pubmed | 8.66e-04 | 26 | 58 | 2 | 26387942 | ||
| Pubmed | Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos. | 8.66e-04 | 26 | 58 | 2 | 37228654 | |
| Pubmed | Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo. | 8.66e-04 | 26 | 58 | 2 | 31655624 | |
| Pubmed | 9.34e-04 | 27 | 58 | 2 | 36197846 | ||
| Pubmed | 9.52e-04 | 115 | 58 | 3 | 20485444 | ||
| Pubmed | Primary cilia control telencephalic patterning and morphogenesis via Gli3 proteolytic processing. | 1.00e-03 | 28 | 58 | 2 | 21490064 | |
| Pubmed | 1.00e-03 | 28 | 58 | 2 | 27965054 | ||
| Pubmed | 1.00e-03 | 28 | 58 | 2 | 20668538 | ||
| Pubmed | Diverse Functions of Retinoic Acid in Brain Vascular Development. | 1.00e-03 | 28 | 58 | 2 | 27445154 | |
| Pubmed | 1.00e-03 | 28 | 58 | 2 | 35112129 | ||
| Pubmed | 1.08e-03 | 29 | 58 | 2 | 25336744 | ||
| Pubmed | 1.08e-03 | 29 | 58 | 2 | 23077214 | ||
| Pubmed | Correct patterning of the primitive streak requires the anterior visceral endoderm. | 1.15e-03 | 30 | 58 | 2 | 21445260 | |
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 1.15e-03 | 30 | 58 | 2 | 32882513 | |
| Pubmed | 1.15e-03 | 30 | 58 | 2 | 28560839 | ||
| Pubmed | 1.15e-03 | 30 | 58 | 2 | 26496195 | ||
| Pubmed | 1.15e-03 | 30 | 58 | 2 | 25804738 | ||
| Pubmed | 1.40e-03 | 33 | 58 | 2 | 30914320 | ||
| Pubmed | PAR3 restricts the expansion of neural precursor cells by regulating hedgehog signaling. | 1.40e-03 | 33 | 58 | 2 | 36218069 | |
| Pubmed | 1.48e-03 | 34 | 58 | 2 | 20007774 | ||
| Pubmed | 1.48e-03 | 34 | 58 | 2 | 12086465 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.51e-03 | 135 | 58 | 3 | 28675934 | |
| Pubmed | 1.66e-03 | 36 | 58 | 2 | 23213481 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q27 | 6.14e-04 | 128 | 59 | 3 | chr3q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 8.22e-04 | 1192 | 59 | 7 | chr19q13 | |
| Cytoband | 9q34.11 | 2.15e-03 | 53 | 59 | 2 | 9q34.11 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 163 | 59 | 5 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D175|Adult / Lineage, Cell type, age group and donor | 4.45e-05 | 148 | 59 | 4 | 012845b10850bbc67814da247ee5a69f6d631eaa | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 4.68e-05 | 150 | 59 | 4 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 157 | 59 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | 11.5-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 6.47e-05 | 163 | 59 | 4 | e9d814952d824539ff1dea119e4fca14a8c335a8 | |
| ToppCell | 11.5-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 6.47e-05 | 163 | 59 | 4 | 31b60e065bac4ad380247964e7574f210106ebae | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-05 | 163 | 59 | 4 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-05 | 163 | 59 | 4 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-05 | 164 | 59 | 4 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-05 | 164 | 59 | 4 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 166 | 59 | 4 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 166 | 59 | 4 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-05 | 166 | 59 | 4 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.44e-05 | 169 | 59 | 4 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.44e-05 | 169 | 59 | 4 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.33e-05 | 174 | 59 | 4 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 9.10e-05 | 178 | 59 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.70e-05 | 181 | 59 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-05 | 181 | 59 | 4 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-05 | 181 | 59 | 4 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.91e-05 | 182 | 59 | 4 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.01e-04 | 183 | 59 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 184 | 59 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.03e-04 | 184 | 59 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-04 | 185 | 59 | 4 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-04 | 185 | 59 | 4 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-04 | 186 | 59 | 4 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 186 | 59 | 4 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.12e-04 | 188 | 59 | 4 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 189 | 59 | 4 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | 2ce330d8078833c05775c481e73770f9ee4a5c88 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | 473c87036e04a058b4a5138438b7ba7e1e766799 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 189 | 59 | 4 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-04 | 190 | 59 | 4 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 191 | 59 | 4 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 191 | 59 | 4 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 191 | 59 | 4 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 191 | 59 | 4 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.19e-04 | 191 | 59 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-04 | 191 | 59 | 4 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-04 | 191 | 59 | 4 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 191 | 59 | 4 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-04 | 191 | 59 | 4 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.19e-04 | 191 | 59 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.22e-04 | 192 | 59 | 4 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 192 | 59 | 4 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 192 | 59 | 4 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.22e-04 | 192 | 59 | 4 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 193 | 59 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 193 | 59 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 193 | 59 | 4 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-04 | 194 | 59 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-04 | 195 | 59 | 4 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.34e-04 | 197 | 59 | 4 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.34e-04 | 197 | 59 | 4 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.37e-04 | 198 | 59 | 4 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-04 | 198 | 59 | 4 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.37e-04 | 198 | 59 | 4 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.37e-04 | 198 | 59 | 4 | d499dced27b0c0e21acfda2c20fa5c114f605085 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.37e-04 | 198 | 59 | 4 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.37e-04 | 198 | 59 | 4 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.37e-04 | 198 | 59 | 4 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.40e-04 | 199 | 59 | 4 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.40e-04 | 199 | 59 | 4 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.40e-04 | 199 | 59 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.40e-04 | 199 | 59 | 4 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | mLN-(6)_Macrophage-(60)_Macrophage|mLN / shred on region, Cell_type, and subtype | 1.40e-04 | 199 | 59 | 4 | 1ea28b832c6173b1b58da432aaf21e6cd291561e | |
| ToppCell | mLN-Macrophage-Macrophage|mLN / Region, Cell class and subclass | 1.40e-04 | 199 | 59 | 4 | 6bbec8450afb30347b07da28401a698fc51a3c53 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-04 | 200 | 59 | 4 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.42e-04 | 200 | 59 | 4 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-04 | 200 | 59 | 4 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.42e-04 | 200 | 59 | 4 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 200 | 59 | 4 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.42e-04 | 200 | 59 | 4 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-04 | 200 | 59 | 4 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-04 | 200 | 59 | 4 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.42e-04 | 200 | 59 | 4 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-04 | 200 | 59 | 4 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-04 | 83 | 59 | 3 | 1ab68323518adc7fd0a459b41fad12d60f97eb5c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-04 | 83 | 59 | 3 | 75b27d91a4473286f4b40027e96ac5246f5abe5b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Slc17a8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.64e-04 | 94 | 59 | 3 | 0dc7e645149fa4255cbe1d288524a1ca7ab66376 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 113 | 59 | 3 | ec4b89e727e1b921b9cb17443774955b95814dd4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Slc17a8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.26e-04 | 119 | 59 | 3 | 6435891e6e33e7ae07e0c3a64a66edfbeedb54be | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 5.66e-04 | 122 | 59 | 3 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1-P1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-04 | 123 | 59 | 3 | e0eb95f1da12687230b47f0a7367b6138bc7ff1a | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-04 | 123 | 59 | 3 | 356e2b1b47fdfc2bb2fcd45e44b452fe811f0fd8 | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-04 | 123 | 59 | 3 | 15f951b4eb2f39888e51e1af18c329953d253f7f | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1-P1_1-Polydendrocyte.Tnr.Tnr_(Tnr)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-04 | 123 | 59 | 3 | b06a38d1081b4485b519853d8c9a2cddfb1e9e75 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-04 | 123 | 59 | 3 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | Cerebellum-Macroglia-POLYDENDROCYTE-P1-P1_1-Polydendrocyte.Tnr.Tnr_(Tnr)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.80e-04 | 123 | 59 | 3 | f60c1dd89da0e204f73772fe0c319eeca82e7e8a | |
| Disease | Diabetic Angiopathies | 3.74e-04 | 16 | 53 | 2 | C0011875 | |
| Disease | sickle cell anemia (is_implicated_in) | 3.74e-04 | 16 | 53 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | Microangiopathy, Diabetic | 3.74e-04 | 16 | 53 | 2 | C0025945 | |
| Disease | lean body mass | 5.89e-04 | 379 | 53 | 5 | EFO_0004995 | |
| Disease | brain age measurement | 5.89e-04 | 20 | 53 | 2 | EFO_0010602 | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 1.16e-03 | 28 | 53 | 2 | DOID:12236 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.58e-03 | 702 | 53 | 6 | C0009402 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 1.71e-03 | 34 | 53 | 2 | DOID:5082 (biomarker_via_orthology) | |
| Disease | Anorectal Malformations | 2.48e-03 | 41 | 53 | 2 | C3495676 | |
| Disease | epilepsy (implicated_via_orthology) | 3.17e-03 | 163 | 53 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 3.25e-03 | 47 | 53 | 2 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | Gastrointestinal Stromal Sarcoma | 3.25e-03 | 47 | 53 | 2 | C3179349 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FPAAVCPPGRAQFGP | 196 | O95936 | |
| FRCPEPIFQPGLLGQ | 121 | Q5JWF8 | |
| PNTGRPFQCIPGYRA | 146 | Q7Z6V5 | |
| FPGFRPAARGLAQCP | 91 | C9JUS6 | |
| LQSCPDPRPFRNGFV | 2221 | Q7Z407 | |
| RCGAFAGPGAPRLPR | 101 | Q9NRK6 | |
| PAEPAQPGACRRDGY | 791 | Q9Y2H0 | |
| LLACAFPAAGSGPPR | 6 | Q8TE60 | |
| ARLAAAGPPGPFRCP | 671 | Q6PCT2 | |
| LRPGDPGFCARARVP | 741 | Q96ST2 | |
| GDQGSPPCFLRFPRP | 6 | O75147 | |
| PRPAVPQTRAFGFCN | 1181 | P10071 | |
| GAPPLQLPRVCTFRF | 131 | Q01167 | |
| PAFGDRRCYQLPPGA | 216 | P13716 | |
| CRVQLGPYQPGRPAA | 176 | Q9BZ67 | |
| GPYQPGRPAACDLRE | 181 | Q9BZ67 | |
| GQELNSPPQPCRRFF | 1206 | O60333 | |
| YEGPVRGLCPFAPRN | 176 | A6ND91 | |
| RLSPKRFPCDFGPGE | 121 | Q5SZK8 | |
| FPFGSEFRPLGPCPA | 601 | Q6ZUT3 | |
| APPPACRFFLEGRCR | 41 | Q96B70 | |
| FGARCRQPHPGAPAP | 56 | Q96B70 | |
| PFLPFQCLQGSGPAR | 561 | Q9Y239 | |
| LGPAAPPRQEAFRLC | 106 | O75074 | |
| PCGPRVAFLPRQAGL | 391 | Q5JZY3 | |
| RPGLGSNPCIPFFYR | 976 | Q08379 | |
| RARLCNNPPPAFGGS | 4666 | Q96RW7 | |
| GDPVPCFIRGAPSFR | 986 | P29474 | |
| AGRAPPELPERNCGY | 6 | P0DPD8 | |
| FNPDRFGPGAPKPRF | 411 | Q9Y6A2 | |
| PEGRAAACFFEQPPR | 111 | Q96MA1 | |
| AACFFEQPPRGRNPG | 116 | Q96MA1 | |
| PGEGGALPRCRPLQF | 201 | Q7Z7A3 | |
| FPAQRGSACRLPAAP | 176 | Q8IX06 | |
| ALHCPFDFPQAPLRG | 46 | Q6ZV80 | |
| LRRCRGGFLEPVFPP | 26 | Q8N5I4 | |
| RNQGPREIPGTAFPC | 11 | Q9H0H9 | |
| YRAPSGRPGPCADVN | 866 | Q8N2S1 | |
| LGFRLQAFPPALCRP | 11 | P48728 | |
| QRFPCQAAARPGPDP | 546 | Q6ZRV2 | |
| PAPQYTGPFCGRARV | 166 | O75995 | |
| AFPNRSAPLVPCRGG | 116 | O75751 | |
| FQRCGLRGLASPPPG | 831 | Q5FWE3 | |
| PGFCPQRTPEGDRAF | 51 | P25940 | |
| PGGAPFAPCKRARFE | 326 | Q5T953 | |
| AFDPPNFPICLLGNR | 301 | Q9H2X9 | |
| GPAPGPAQLRCYAGR | 36 | P51649 | |
| RENPCFPLPAAGGSR | 61 | O75920 | |
| IPPGLRPRFCAFGGN | 141 | O15446 | |
| RPRFCAFGGNPPVTG | 146 | O15446 | |
| AGRAPPELPERNCGY | 6 | P0DPD7 | |
| GGLCFPDFPRKQVRG | 176 | Q96QV1 | |
| PAFFPGRCAEIFARG | 541 | Q9NSD9 | |
| EQLRRVFGNCLPPFP | 46 | Q8N9S9 | |
| RPPFLPQRHAAGQCG | 6 | P28702 | |
| PGRPRDPNTCFFEGQ | 696 | Q9H2X0 | |
| CGLALPVPRPLAFGQ | 101 | Q8WTU2 | |
| CAAPGGVRKAPAPFR | 136 | Q9C0C2 | |
| PSADCGPFRGLPLFI | 861 | Q6UXY8 | |
| GFHCLPCPPRYRGNQ | 616 | P35442 | |
| QAPGPLGERIFPLFC | 391 | Q9H2S5 | |
| AAGLDFAPGLPCAPR | 356 | A6NJT0 | |
| AAVEPRCPFPAGAAL | 21 | Q147X3 |